).
Male birds are homogametic (ZZ; females: ZW) and dosage compensation is limited (18) , so Z-genes might contribute to masculinisation of the brain. Microarray and subsequent studies identified several Z-genes that may be involved (19) (20) (21) (22) (23) . One is tubulin specific chaperone A (TBCA), a protein critical for b-tubulin formation (24, 25) . A specific sex difference in TBCA expression within the song system exists. In development, but not adulthood, TBCA is increased in males compared to females only in the LMAN. A majority of these TBCA+ cells are neurones, many of which project to the RA (26, 27) . Thus, TBCA is positioned to influence sexually dimorphic development of RA.
The present studies represent an initial step in evaluating the idea that both E 2 and Z-gene(s) are required for full masculinisation of the song circuit. In addition to testing the direct effects of inhibiting TBCA in the LMAN of juvenile birds, we evaluated two ways in which TBCA might interact with E 2 to facilitate masculinisation. We investigated whether E 2 increases TBCA availability in the LMAN and also tested whether TBCA in the LMAN modulates the ability of E 2 to masculinise the song circuit.
Materials and methods

Animals and tissue collection
Zebra finches were reared in walk-in aviaries, each of which contained five to seven male and female pairs with their offspring. Nest boxes were checked every day, and new hatchlings were toe-clipped for unique identification. Portions of the removed toes were used to determine the genetic sex of each individual by polymerase chain reaction (28) . Animals were kept under a 12 : 12 h light/dark cycle, and provided seed (Kaytee Finch Feed; Chilton, WI, USA), water, gravel and cuttlebone ad lib. Each week, their diets were supplemented with spinach, oranges, hard-boiled chicken eggs and bread.
For all studies, birds were killed by rapid decapitation, and their brains were removed and immediately frozen in cold methyl-butane. Tissue was stored at À80°C with desiccant until processing. All procedures were conducted in accordance with the National Institute of Health guidelines for the care and use of laboratory animals and were approved by the Institutional Animal Care and Use Committee (IACUC) of Michigan State University.
Experiment 1: Effects of increasing E 2 on TBCA expression in the LMAN
Hormone manipulation
On D3, each male and female bird received a s.c. implant of either E 2 or a blank control, in accordance with Tang and Wade (29) . Implants were synthesised using a 1 : 5 uniform mixture of 17b-oestradiol (Steraloids, Welton, NH, USA) and silicone sealant (Type A; Dow Corning, Midland, MI, USA), which was extruded through a 3-ml syringe in a straight line onto waxed paper and dried overnight. The mixture was cut into 1-mm lengths, which were then further divided to provide 100 lg of E 2 per pellet. Blank capsules were produced the same way without the addition of the hormone. Brains were collected at D25, as noted above, and processed for either immunohistochemistry (IHC) or in situ hybridisation to detect protein and mRNA, respectively. At this time, all birds were checked to confirm the continued presence of the pellet and that those with oestradiol still contained some crystalline hormone.
Immunohistochemistry
Brains (n = 7 per sex per treatment) were coronally sectioned at 20 lm, and thaw-mounted in six series onto SuperFrost Plus slides (Fisher Scientific, Pittsburgh, PA, USA). The TBCA primary antibody was validated in accordance with Qi and Wade (27) , where the IHC protocol is described in detail. Briefly, one series of slides was warmed to room temperature, rinsed in 0.1 M phosphate-buffered saline (PBS) and fixed in 4% paraformaldehyde. Tissue was then treated with 0.9% hydrogen peroxide in methanol, incubated in 5% normal goat serum (NGS) in PBS with 0.3% Triton X-100, and finally incubated in TBCA primary antibody (2 lg/ml #SAB1100935; SigmaAldrich, St Louis, MO, USA) in 0.1 M PBS containing 0.3% Triton X-100 and 5% NGS for 24 h at 4°C. The next day, after rinses in PBS, the tissue was incubated in a biotin-conjugated goat anti-rabbit secondary antibody (1 lg/ 2 ml #BA-1000; Vector Laboratories, Burlingame, CA, USA) for 2 h at room temperature. The protein was visualised with Elite ABC reagents (Vector Laboratories) in accordance with the manufacturer's instructions, including diaminobenzidine (Sigma-Aldrich) with 0.0024% hydrogen peroxide. After the colour reaction, slides were rinsed in PBS, dehydrated in a series of ethanols and coverslipped with DPX (Sigma-Aldrich).
TBCA protein labelling in the LMAN was quantified using STEREO INVESTIGATOR software (Microbrightfield, Inc., Williston, VT, USA) without knowledge of the animal's sex or treatment. The optical fractionator function was used to estimate the total number of TBCA positive cells in and the volume of the LMAN. Labelled cells were defined as those with a distinct neuronal morphology exhibiting a brown cytoplasmic reaction product. The borders of the LMAN on one side of the brain (randomly selected) were defined by tracing its edge, and the number of cells within it was determined manually in sampling sites determined by the software. The density of TBCA labelled cells was calculated by dividing the estimate of the total number by the volume of the LMAN. Parameters for acceptable coefficient of errors were based on Slomianka and West (30) .
A two-way ANOVA was used (SPSS, version 21.0; IBM Armonk, NY, USA) to analyse the effects of sex and treatment on the estimated total cell number, volume defined by TBCA labelling and density of labelled cells in the LMAN.
In situ hybridisation
Adjacent tissue sections from the same animals used in the IHC study were used for in situ hybridisation. One E 2 treated female and one control male were not included because their tissues were used for another study (final sample sizes for males: E 2 = 7, blank = 6; females: E 2 = 6, blank = 7). Two adjacent sets of tissue sections from each animal were used: one for antisense and one for control, sense probes. The probes and protocol were the same as described in Qi et al. (26) . Briefly, the tissue was rinsed in PBS, fixed in 4% paraformaldehyde and dehydrated in a series of ethanols. The slides were then incubated in pre-hybridisation buffer for approximately 2 h before they were exposed to 33 P-UTP-labelled RNA probes overnight (20-24 h ). The tissue was washed in saline-sodium citrate buffers to remove excess probe and then dehydrated in a series of ethanols. Representative slides from each group were exposed to a phosphor-imaging screen (Kodak #170-7841; Bio-Rad, Hercules, CA, USA) for 16 h and scanned with a Molecular Imager FX (Bio-Rad) to confirm the signal in the LMAN. Slides were then dipped in NTB emulsion (Eastman Kodak, Rochester, NY, USA) and stored in the dark at 4°C for 5 weeks. They were then developed using Kodak D-19 developer and fixer (Eastman Kodak) and lightly counter-stained with cresyl violet to facilitate identification of the brain anatomy.
The analysis was also completed in the same manner as that described in Qi et al. (26) , without knowledge of each animal's sex or treatment group. The LMAN was first identified using bright field microscopy, and then captured in dark field using IMAGEJ (National Institutes of Health, Bethesda, MD, USA). The threshold function was used to manually define the silver grains covering a box (0.052 mm 2 ) placed over the centre of the LMAN. The software calculated the percentage of this area covered by this labelling. This procedure was used in each section containing LMAN on both the left and right sides of the brain. Background labelling from adjacent sections that were exposed to the sense probe was subtracted from values obtained from anti-sense treated sections. The resulting values were averaged within individuals.
A two-way ANOVA was used to analyse the effects of sex and treatment on the percent area covered by silver grains in the LMAN.
Nissl staining
A final series of sections (n = 7 per sex per treatment) was stained with thionin to validate that the E 2 treatment had an effect on the brain. Area X is not normally visible in females, although it becomes distinct after posthatching E 2 treatment (31). Females were inspected for the presence or absence of Area X by an observer who was blind to hormone treatment. In addition, because we are unaware of any report of the effects of early E 2 on juvenile LMAN volume [but, for adult brains, see Grisham et al. (32) ], the volume of this region was quantified in all individuals. Cross-sectional areas were determined by tracing the border of LMAN on each side of the brain using IMAGEJ in each section that it was visible. Unilateral volumes of the brain region were estimated by multiplying the sum of these areas by the sampling interval (0.12 mm). Values for the left and right sides of the brain were averaged. A two-way ANOVA was used to analyse the effects of sex and treatment on LMAN volume.
Experiment 2: Effects of TBCA inhibition and E 2 modulation on song system morphology Validation of TBCA small interfering (si)RNA manipulation siRNAs were generated by Ambion (Custom Ambion in vivo siRNA; Ambion Life Technologies, Carlsbad, CA, USA) based on the TBCA mRNA sequence from GenBank (Accession number DQ214986). Three sequences, each of 21 nucleotides, were designed for maximum efficacy and of a size (< 30 nucleotides) that should not initiate nonspecific protein synthesis or RNA degradation. These sequences were combined for transfection into a pseudoviral envelope. This haemagglutinating virus of Japan envelope (HVJ-E; Genome-ONE-Neo EX HVJ-E; Cosmo Bio Co., Ltd, Koto-ku, Tokyo, Japan) is a replication-incompetent vector developed from the Sendai virus (33) . The viral genome is inactive, and only the cell membrane fusion properties are intact, allowing effective delivery of siRNAs into cells without eliciting a cytotoxic response (34) .
A pilot study (n = 3 males/group) assessed degree of protein knockdown using several siRNA doses (10, 20, 30 pM) across survival times (4, 7, 10 days). The three sequences were first diluted in nuclease free water to achieve the three concentrations, and stored at À20°C until use. Before surgery, each siRNA dose was transfected into a pellet containing the HVJ-E vector, in accordance with manufacturer's instructions for the treatment of laboratory animals. A control sequence (Control siRNA-J: sc-44238; Santa Cruz Biotechnology, Santa Cruz, CA, USA) was prepared in the same way and transfected at the same time. Similar to the other siRNAs, this sequence of comparable length activates the RISC complex but does so without degradation of a target as a result of a lack of complementarity to any known cellular mRNA. Based on the results of this study, a more comprehensive analysis was conducted using the 30 pM dose and the 10-day survival time that included both males (n = 6) and females (n = 7).
For all intracranial injections, birds were anaesthetised with isoflurane, and positioned in a stereotaxic instrument (model 900; KOPF Instruments, Tujunga, CA, USA). Injections into the LMAN were unilateral, so that one hemisphere received TBCA siRNA, whereas the contralateral side received the control sequence. Injections were 4.8 mm anterior to the bifurcation of the midsaggital sinus (lambda), 2.0 mm lateral to the midline and 1.5 mm ventral from the surface of the skull. siRNA and the control (1 ll each) were infused over 5 min, at a rate of 0.2 ll/min. All animals were returned to their home aviaries until they were killed.
Animals were killed by rapid decapitation, and their brains were immediately frozen in cold methyl-butane and stored at À80°C until sectioning. Brains were coronally sectioned at 300 lm and thaw-mounted onto SuperFrost Plus slides. As described in Qi and Wade (27) , LMAN was removed using a 17-gauge micropunch (Stoelting, Wood Dale, IL, USA). For each animal, three punches were obtained from the centre of the LMAN in each hemisphere, and were pooled within an animal. Punches from the two sides of the brain were kept separate to distinguish between the siRNA and control treatments. Tissue punches were immediately suspended in cold RIPA lysis buffer (Santa Cruz Biotechnology) and homogenised using a sonic dismembrator (Fisher Scientific). Samples were then centrifuged at 10 000 g for 10 min at 4°C. The protein supernatants were collected, and a small volume of each sample was used for concentration quantification using the Bio-Rad Protein Assay (Bio-Rad Laboratories). The remainder of each sample was stored at À20°C until western blot analysis.
Protein (30 lg) per sample was loaded into 4-20% mini-protean TGX gels (Bio-Rad Laboratories) along with a Kaleidoscope pre-stained standard (Bio-Rad Laboratories). Samples were divided among seven gels, although the proteins from the two sides of the brain for each individual were always on the same gel. Male and female samples were run on separate gels because of differences in optimal film exposure times. Separated samples were transferred to polyvinylidene fluoride membranes (Millipore, Billerica, MA, USA) at 4°C. Membranes were then cut in half so that TBCA (13 kDa) and the loading control, actin (43 kDa), could simultaneously be probed.
Each membrane was incubated in 5% nonfat milk for 1 h at room temperature to prevent nonspecific binding. TBCA (2 lg/ml) and actin primary antibodies (1 lg/ml; #SC-1615; Santa-Cruz Biotechnology) were applied to their respective membranes at 4°C overnight. The blots were exposed to horseradish peroxidase-linked secondary antibodies for TBCA (dilution 1 : 5000; #7074; Cell Signaling Technology Inc., Danvers, MA, USA) and for actin (1 lg/ 15 ml; #SC-2020; Santa-Cruz Biotechnology). After washes in PBS, the membranes were processed for enzyme-linked chemiluminescent detection (ECL Plus; GE Healthcare, Pittsburgh, PA, USA) followed by exposure to autoradiography film (HyBlot CL; Denville Scientific Inc., Metuchen, NJ, USA). The film was developed using Kodak Professional D-19 developer and fixer.
A ratio of the optical densities of TBCA and actin, corrected for neighbouring background, was calculated for each animal using IMAGEJ. Paired t-tests were used to evaluate differences between siRNA and control samples within males and females.
Hormone manipulations in experimental animals
Females were administered either an E 2 or blank implant on D3 as in Experiment 1. Also starting on D3, and continuing until they were killed, male birds received daily injections of 20 lg of fadrozole hydrochloride (SigmaAldrich) in 10 ll of 0.75% saline into the breast muscle. This manipulation is highly effective in reducing brain aromatase in developing zebra finches (35) . Control males received the same volume of 0.75% saline. Each bird then received a manipulation of TBCA in the LMAN. Two studies were conducted: one to assess morphology within the LMAN and RA, and the other to quantify the projection between these regions.
Morphology of the LMAN and RA
Between D15 and D17, males and females received stereotaxic injections of TBCA siRNA and control siRNA into the LMAN, as described above. One bird was eliminated from analysis because of damaged tissue in the LMAN, and two were not used because the injection sites were lateral to the LMAN. Final sample sizes are indicated below. Birds were returned to their home aviaries after surgery and killed 10 days later. Their brains were removed and immediately frozen in cold methyl-butane and stored at À80°C. They were coronally sectioned at 20 lm, and thaw-mounted in six series onto SuperFrost Plus slides.
One series of slides from each animal (final sample sizes for males: fadrozole = 10, saline = 9; females: E 2 = 7, blank = 9) was processed for TBCA immunoreactivity to confirm the efficacy of the siRNA treatment in the LMAN. The protocol for TBCA IHC was identical to that used in Experiment 1. Photographs of LMAN were captured using IMAGEJ and each image was coded so that hormone treatment, side of brain and sex were blind to the observer. To obtain an estimate of relative numbers of TBCA+ cells in the LMAN, the cell counter plug-in in IMAGEJ was used to mark individual cells within this region. As in Experiment 1, TBCA+ cells were defined as those with a distinct neuronal morphology exhibiting a brown cytoplasmic reaction product for the DAB. An estimate of relative TBCA+ cell numbers for each side of LMAN was obtained by taking the average of the cell counts through each section in which LMAN was identifiable. The possibility that a cell was counted twice is extremely low because alternate tissue sections were 0.12 mm apart. The average across sections was used because for a few individuals, cells could not be reliably counted in one section because of extremely light labelling.
A second series of slides from each animal (final sample sizes for males: fadrozole = 11, saline = 9; females: E 2 = 7, blank = 9) was stained with thionin for confirmation of accurate injections into LMAN and for analysis of morphology in both the LMAN and its target (i.e. RA). Photographs of each section containing the LMAN and RA were captured using IMAGEJ, and the files were coded so that hormone treatment, side of brain and sex were blind to the observer. Cross-sectional areas and volumes of the LMAN and RA were determined as in Experiment 1. Cell counts were obtained in the RA of thionin-stained sections in the same manner as TBCA labelled cells were quantified in the LMAN. However, because these cells were readily quantifiable in every tissue section, a total of the counts was analysed rather than an average per section.
To obtain an estimate of soma size in the RA, the borders of 20 randomly selected cells were traced within each of the three most anterior sections of RA using IMAGEJ. Values from the two sides of the brain were kept separate so that comparisons could be made within each animal. Averages were calculated from the 60 cells per hemisphere.
Mixed model ANOVAs (siRNA within animals, hormone manipulation between individuals) were used to analyse each variable: number of TBCA+ cells, volumes of LMAN and RA, as well as RA cell size and number, based on Nissl staining. These analyses were conducted separately for males and females because they received different methods of hormone administration (injections versus implants).
LMAN to RA projection
Between D15 and D17, males and females received stereotaxic injections of TBCA siRNA and its control into LMAN, as described above. In this set of birds, however, immediately after siRNA injections, cannulae were replaced within their guides and 1 ll of 1,1 0 -dioctadecyl-3,3,3 0 ,3 0 -tetramethylindocarbocyanine perchlorate (DiI; Molecular Probes, Invitrogen, Carlsbad, CA, USA; 0.1% in dimethylsulphoxide) was infused over 5 min at a rate of 0.2 ll/min into both sides of the LMAN. Birds were returned to their home aviaries after surgery and killed 10 days later. The brains were removed, immediately frozen in cold methyl-butane, and stored at À80°C. They were coronally sectioned at 20 lm, and thaw-mounted in six series onto SuperFrost Plus slides. One series of slides from each animal was stained with thionin to confirm that the injection site was limited to the LMAN. Microscopic inspection of the tissue showed that a few animals received DiI ventral to the LMAN, and some exhibited unequal amounts of DiI in the two hemispheres. These were not included in the analysis (final sample sizes were males: fadrozole = 7, saline = 6; females: E 2 = 11, blank = 9). A second series of slides was processed for quantification of DiI in the RA. Slides were warmed to room temperature, rinsed in 0.1 M PBS, and fixed in 4% paraformaldehyde. They were then rinsed in PBS, dipped in water and cover-slipped with ProLong Gold mounting medium (Ambion Life Technologies). Slides cured at room temperature for 48 h, and were then stored in the dark at 4°C until analysis.
Photographs of RA were captured using IMAGEJ under a TRITC filter, and the images were coded so that treatment and sex were blind to the observer for analysis. Adjacent tissue sections from the Nissl-stained slides were used to confirm the anatomical resolution of the RA. The border was traced in the fluorescent images in every section in which the brain region was visible. The threshold function (default settings) was then used to manually highlight the DiI labelling within each RA trace. IMAGEJ calculated the percentage of the cross-sectional area for the RA that was covered by DiI. Values within each side of RA in each animal were averaged, and a mixed model ANOVA was used to analyse the effects of siRNA treatment (within animals) and hormone manipulation (between animals). Males and females were also kept separate for these analyses.
Results
Experiment 1: E 2 does not increase TBCA mRNA or protein In situ hybridisation
As expected, increased TBCA mRNA was detected in the LMAN of males compared to females, as indicated by a main effect of sex in silver grain density (F 1,22 = 21.92, P < 0.001) (Fig. 1A,B) . However, no effect of treatment (F 1,22 = 0.470, P = 0.500) or interaction between sex and treatment (F 1,22 = 0.832, P = 0.372) was observed.
Immunohistochemistry
Effects of sex and treatment were not detected on the estimated number of cells expressing TBCA protein, and the variables did not interact (all F 1,24 < 2.91, P > 0.100) (Fig. 1C) . However, the volume defined by this labelling was greater in males than in females (F 1,24 = 5.844, P = 0.024) (Fig. 1D) . Neither an effect of E 2 , nor an interaction between E 2 and sex was detected on this measure (both F 1,24 < 2.26, P > 0.145). There were no main effects of sex or hormone treatment on the density of labelled cells, and the variables did not interact (all F 1,24 < 1.66, P > 0.200; not shown).
Nissl staining
No effects of sex or E 2 were detected on the volume of LMAN (all F 1,24 < 2.47, P > 0.128; not shown).
Experiment 2: TBCA siRNA in the LMAN effectively inhibits local protein expression, and demasculinises the LMAN and RA, as well as the projection between them siRNA effectiveness Western blot analyses used to validate the treatment paradigm indicated that TBCA-specific siRNA significantly decreased relative levels of this protein, compared to the control treatment, in both females (t 6 = 4.144, P = 0.006) and males (t 5 = 2.631, P = 0.046) (Fig. 2) . In females, protein was decreased by 59% on average and, in males, it was decreased by 71%. Analysis of the loading control, actin, alone indicated no effect of the siRNA manipulation in either females (t 6 = 0.493, P = 0.640) or males (t 5 = 1.256, P = 0.265), suggesting specificity of the manipulation.
In alternate sections used for the quantification of morphology (see below), we used IHC to confirm effectiveness of the siRNA manipulation in experimental animals. This treatment significantly reduced the average number of detectable TBCA+ cells per section of LMAN in both females (F 1,14 = 8.234, P = 0.012) and males (F 1,17 = 15.81, P = 0.001; not shown).
Effects of siRNA and hormone manipulation on LMAN volume
In females, TBCA siRNA significantly decreased LMAN volume in thionin-stained tissue (F 1,14 = 5.325, P = 0.037) (Fig. 3A) , although there was no main effect of hormone treatment (F 1,14 = 0.377, P = 0.549) or interaction between the variables (F 1,14 = 0.142, P = 0.712). In males, the TBCA siRNA manipulation did not reduce LMAN volume (F 1,18 = 2.261, P = 0.150) (Fig. 3B ) and no interaction between siRNA and hormone treatments was detected (F 1,18 = 2.375, P = 0.141). There was, however, a main effect of hormone treatment, such that the volume of LMAN was greater in males treated with fadrozole than saline (F 1,18 = 8.672, P = 0.009).
Effects of siRNA and hormone manipulation on the RA Parallel to its influence on the LMAN, TBCA siRNA reduced RA volume in females as quantified in Nissl-stained tissue (F 1,14 = 23.14, P < 0.001) without a main effect of hormone treatment or an interaction between the variables (both F 1,14 < 1.72, P > 0.211) (Fig. 3C) . Here, the effect was the same in males, with TBCA siRNA reducing RA volume (F 1,18 = 13.01, P = 0.002). No main effect of fadrozole or interaction between the siRNA and fadrozole manipulations existed (both F 1,18 < 1.02 P > 0.326) (Fig. 3D) .
The estimate of relative cell number in the RA was also decreased in females by the TBCA siRNA manipulation (F 1,14 = 10.78, P = 0.005), without a main effect of hormone treatment or an interaction between E 2 and the siRNA (both F 1,14 < 0.26, P > 0.619) (Fig. 4A) . The pattern was the same in males, with a main effect of siRNA treatment reducing RA cell number (F 1,18 = 21.22, P < 0.001) (Fig. 4B ) and no effect of hormone manipulation or interaction between the two variables (both F 1,18 < 1.23, P > 0.282).
Finally, RA soma size was also reduced in females as a result of the siRNA compared to control treatment (F 1,14 = 16.97, P = 0.001), with no effect of hormone treatment or interaction between the variables (both F 1,14 < 1.67, P > 0.217) (Fig. 4C) . A parallel main effect of the siRNA existed in males (F 1,18 = 47.33, P < 0.001) (Fig. 4D,E) . Fadrozole also increased this measure (F 1,18 = 5.290, P = 0.034), although no interaction between siRNA and hormone treatment was detected (F 1,18 = 1.366, P = 0.258).
Effects of siRNA and hormone manipulation on the projection from the LMAN to the RA The percentage of area covered by DiI in the RA after administration to LMAN was diminished by TBCA siRNA treatment in both females (F 1,18 = 5.378, P = 0.032) (Fig. 5A ,C-E) and males (F 1,11 = 7.105, P = 0.022) (Fig. 5B) . In females, there was no main effect of E 2 treatment (F 1,18 = 0.102, P = 0.753) or interaction between siRNA and hormone (F 1,18 = 3.953, P = 0.062). However, in males, fadrozole significantly increased the percentage area of RA covered by DiI (F 1,11 = 10.26, P = 0.008). No interaction existed between siRNA and fadrozole treatment (F 1,11 = 1.760, P = 0.211).
Discussion
To our knowledge, this is the first set of studies to document specific effects of a sex chromosome gene on avian brain development. Inhibition of TBCA in the LMAN demasculinised soma size and cell number in the RA, as well as RA volume. It also diminished the projection from the LMAN to the RA. Parallel effects occurred in females, with an additional reduction in LMAN volume. However, the role of E 2 remains unclear. Although we had considered additive or interactive effects of this hormone and TBCA on masculinisation, the results suggest that neither occurs.
TBCA is involved in song system masculinisation TBCA is conserved across vertebrates and is one of several chaperones required for the generation of a/b tubulin (36) . Human mutations in a b-tubulin gene, TUBB2B, are associated with defective TBCA and result in reduced tubulin heterodimers and abnormal brain development (37) . TBCA silencing in mammalian cell lines causes a reduction in soluble tubulin and, eventually, the death of these cells (38) . Thus, TBCA in mammalian systems is important for cell survival and normal brain maturation.
The present data on TBCA inhibition are consistent with similar roles in zebra finches. Effects were detected in both sexes despite lower endogenous TBCA levels in females (26, 27) , suggesting that this Z-gene acts in a similar manner regardless of the genetic sex of the brain and its relative availability likely influences sex differences in song system morphology. The results parallel those from electrolytic lesions of LMAN (9) and ibotenic acid lesions of MAN (10) in juvenile males, which reduce the volume of and cell number in RA. LMAN cells can transport neurotrophins, including brain-derived neurotrophic factor (BDNF), to RA, and infusion of these proteins into RA rescues cell death after deafferentation (11) . Thus, the projection from LMAN to RA likely facilitates RA cell survival by providing trophic support. Future work should assess the direct effects of TBCA inhibition in LMAN on BDNF transport to the RA.
The present results differed a bit from Akutagawa and Konishi (10) in that a reduction in RA cell size was not seen after their MAN lesions. It is difficult to speculate on why our relatively specific manipulation in the LMAN produced an effect not seen with the more global destruction of a brain region. However, the difference on this measure may be related to timing, as that previous study manipulated the brain region several days later than we did (D20) and collected the tissue far later (in adulthood). The RAs analysed in our experiment would not yet have received input from the HVC, although they would have in the earlier work; the projection develops in males at approximately 1 month of age. E 2 does not affect TBCA expression in the LMAN E 2 treatment did not modulate TBCA mRNA or protein in the LMAN of juvenile birds of either sex. We had hypothesised that one mechanism by which E 2 might facilitate masculinisation, at least when administered to females, is via up-regulation of this protein that is important for neural development. However, the data from Experiment 1 indicate that an increase in circulating levels of this steroid has no effect on TBCA expression in the LMAN of either sex. Consistent with previous results from juvenile zebra finches (27) , TBCA mRNA was greater in the LMAN of males in the present study, although the number of TBCA immunoreactive cells in this brain region did not differ between the sexes. The volume defined by this labelling but not Nissl staining was greater in males. Similarly, a previous assessment of changes in the volume of LMAN in Nissl-stained tissue produced no main effect of sex and parallel developmental trajectories in males and females (39) . In our earlier experiment (27) , western blot analysis showed a greater concentration of protein in the LMAN of males compared to females at D25. Collectively, these results suggest that the quantity of TBCA per cell may be greater in males. Such a result might make individual cells appear larger in immunostained tissue, which could affect the detection of the borders of the LMAN.
Manipulation of E 2 availability produced some novel results
Previous work has documented effects of post-hatching E 2 in females on masculinising RA morphology (4) that were not seen in Experiment 2. All females treated with E 2 in the present study had an Area X, which is normally not visible without early exposure to E 2 , whereas none of those receiving blank capsules did. Thus, the steroid functioned in the brains of these birds. Although sites of E 2 action on song system structure are not clear, during the period of treatment described in the present study, oestrogen receptor (ER) a mRNA has been detected in the HVC and RA but not in the LMAN or Area X (40) . Cells in the HVC and RA are also immunoreactive for the G-protein-coupled membrane bound ER, GPR30, across several juvenile ages (41) .
One possibility for the lack of effects in the RA is that mechanical injury caused by inserting cannulae into the LMAN up-regulated aromatase (42) . Recent studies in mice suggest that such an increase in oestrogen synthesis can even propagate to beyond the site of injury (Saldanha CJ, Mehos CJ, Blackshear K, and Duncan KA, unpublished observations). Thus, it is possible that E 2 levels were increased in both the LMAN and RA in all of the subjects, which minimised any effects that might have been a result of exogenous hormone manipulation.
In males, aromatase inhibition increased RA cell size and LMAN volume, as well as the transport of DiI from the LMAN to the RA. This information on LMAN volume and the projection to the RA is new; these variables had not been evaluated previously after experimental blockade of post-hatching oestradiol synthesis. Data on RA volume in the present study are consistent with earlier work (13); neither study found an effect of fadrozole treatment of juvenile males. However, unlike the present study, the earlier experiment also found no effect on RA cell size. The reason for the difference across the studies is not obvious. The doses were identical, although the earlier experiment treated males from D1 to D30, whereas the present birds were injected from D3 to D25-27. The ages of injected birds are different, although it is unlikely that a shorter duration would have a more potent outcome.
Hypermasculinising effects after manipulation of oestrogenic systems have been detected in zebra finches. Administering the oestrogen receptor blockers tamoxifen, LY117018 or CI628 to males increases a variety of aspects of song system morphology (15, 16) . Although the mechanisms are unclear, it appears that increased oestrogen availability or action in males has some opposing effects in males and females. These ideas warrant further investigation.
Fadrozole might also have affected brain morphology in the present study by increasing androgen availability. Androgen receptor mRNA is found in both the RA and LMAN of zebra finches (43) . Inhibiting aromatase activity increases available testosterone because less of this substrate is metabolised (44, 45) . Similar to the data from studies on E 2 , the results from manipulations of androgen or its ability to act are somewhat paradoxical. Treatment of juvenile female zebra finches with 5a-dihydrotestosterone, a nonaromatisable metabolite of testosterone, can increase RA soma size and cell number (46, 47) . However, data obtained after administration of the anti-androgen flutamide are inconsistent. In one study, treatment of developing males with this drug had no effect on numerous measures of song system morphology, including RA soma size (48) . In another, it hypermasculinised volume and neurone number in the RA (47) . In a third, castration of juvenile males combined with treatment with the anti-androgen, flutamide, decreased LMAN volume (49) . Some, but not all of these data, are consistent with the hypermasculinising effects that we detected in the LMAN and RA after fadrozole treatment; more work is needed to isolate specific mechanisms.
Details regarding the increase in the projection from the LMAN to the RA as a result of fadrozole treatment also need to be further evaluated. However, we can conclude that the mechanisms are different than those involved in masculinising the projection from the HVC to the RA. This male-specific innervation (50,51) is critical for normal RA development in older birds (10) and it does appear to require E 2 produced in the brain (12) .
Future directions
The history of research into the mechanisms underlying sexual differentiation of the zebra finch song system suggests that both Z-genes and E 2 may be important for masculinisation. The present studies demonstrate that inhibition of a specific Z-gene, TBCA, influences song system development. Although siRNA manipulation did not fully demasculinise morphology, several reliable effects were detected in both the LMAN and its target (i.e. RA), suggesting a role for TBCA in maturation of the neural song system. At least two factors likely account for the magnitude of the effects we detected. The first reflects technology: TBCA protein was not completely eliminated. The second involves biological mechanisms in that numerous additional genes are likely responsible for particular aspects of song system differentiation. Some of these genes may be on the Z-chromosome; candidates are currently under investigation. Importantly, although TBCA does not appear to be regulated by E 2 , and it does not modulate the effects of E 2 in the brain, other Z-genes may interact with this hormone to influence masculinisation of the song system. Tyrosine kinase receptor B (TrkB), the high affinity receptor for BDNF, is one possibility. Expression of both the ligand and receptor in the song system is sexually dimorphic and modulated by E 2 (29,52). Finally, not only is it possible that multiple Z-genes influence masculinisation, but W-genes, which are specific to females, may facilitate feminisation. The present work represents an initial series of steps in determining the role of sex chromosome genes in the development of brain and behaviour. These ideas must now be investigated more broadly.
